Have a personal or library account? Click to login
In medicine today – Cancer and the prorogation of clinical reality in favour of probabilistic outcomes Cover

In medicine today – Cancer and the prorogation of clinical reality in favour of probabilistic outcomes

By: Spyros Retsas  
Open Access
|Nov 2024

References

  1. Wechsler LR. Statins and Stroke - It’s Complicated. N Engl J Med 2020; 382:81–82
  2. Jolobe Oscar M.P. Titration of antihypertensive therapy to mitigate the risk of falls. LETTERS TO THE EDITOR. Clinical Medicine 2022 Vol 22 No 6:597. DOI 10.7861/clinmed.Let.22.6.1
  3. Jenei K, Moraes FY, Gyawali B. Globalisation of clinical trials in oncology: a double-edged sword? BMJ Oncology 2023;2:e000163. doi:10.1136/bmjonc-2023-000163
  4. Kirkwood JM, Strawderman MH, Ernstoff Ms, et al: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14:7–17.
  5. Williams MV, De Takats P, Parmar M. Survival benefit in melanoma. J Clin Oncol, 1997; 15, No 5 (May), 2172.
  6. Davis C, Naci H, Gurpinar E, et al. Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009–13. BMJ 2017;359: j4530 http://dx.doi.org/10.1136/bmj.j4530
  7. Wise PH. Cancer drugs survival and ethics BMJ 2016;355: i5792
  8. Van Oosterom At, Judson Ir, Verweij J, Stroobants S, Dumez H, Donato Di Paola E, Sciot R, Van Glabbeke M, Dimitrijevic S, Nielsen Os; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumours: a report of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer. 2002 Sep;38 Suppl 5:S83–7. doi: 10.1016/s0959-8049(02)80608-6. PMID: 12528778.
  9. Rigo R, Doherty J, Koczka K, Kong S, Ding Pq, Cheng T, Cheung Wy, Monzon Jg. Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis. Curr Oncol. 2021 Oct 5;28(5):3978–3986. doi: 10.3390/curroncol28050338.
  10. Ioannidis JPA, Haidich A-B, Lau J. Any casualties in the clash of randomised and observational evidence? No—recent comparisons have studied selected questions, but we do need more data. BMJ 2001;322:879–80
  11. Medical Research Council: Streptomycin treatment of pulmonary tuberculosis. BMJ 1948:769–782,
  12. Hellman S, Hellman Ds: Of mice but not men: Problems of the randomized clinical trial. N Engl J Med 1991; 324:1585–1589.
  13. Yokota T, Kojima S, Yamauchi H, Hatori M. Evidence-based medicine in Japan. www.thelancet.com 2005; Vol 366 July 9, 122.
  14. WU J. Could evidence-based medicine be a danger to progress? www.thelancet.com 2005; Vol. 366 July 9, 122.
DOI: https://doi.org/10.2478/fco-2023-0033 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 12 - 14
Submitted on: Feb 19, 2024
Accepted on: Jun 13, 2024
Published on: Nov 26, 2024
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2024 Spyros Retsas, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.